Hepatic SIRT6 protects against cholestatic liver disease primarily via inhibiting bile acid synthesis
{{output}}
Cholestatic liver disease, caused by the accumulation of hazardous bile acids in the liver, may result in cirrhosis, fibrosis, or liver failure. Activation of SIRT6 prevents cholestasis-associated pathological events, such as oxidative stress and mitochondrial... ...
